Skip to main content

Advertisement

Log in

Skeletal fragility: an emerging complication of Ehlers–Danlos syndrome

  • Clinical Management of Endocrine Diseases
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Ehlers–Danlos syndrome (EDS) is an emerging cause of skeletal fragility. Mechanism of bone damage are probably multifactorial in line with the different skeletal phenotypes that can be found in clinical practice. A structured approach to clinical management of bone metabolic complication in EDS is proposed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. B. Steinmann, P.M. Royce, A. Superti-Furga, in: Connective Tissue and Its Heritable Disorders, ed. by P.M. Royce, B. Steinmann (Wiley-Liss: New York, NY, USA, 2002), pp. 431–524

  2. F. Malfait, C. Francomano, P. Byers, J. Belmont, B. Berglund et al. The 2017 international classification of the Ehlers–Danlos syndromes. Am. J. Med. Genet. 175C, 8–26 (2017)

    Article  Google Scholar 

  3. M. Colombi, C. Dordoni, N. Chiarelli, M. Ritelli, Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type compared to other heritable connective tissue disorders. Am. J. Med. Genet. 169, 6–22 (2015)

    Article  Google Scholar 

  4. M. Ritelli, M. Venturini, C. Dordoni, N. Chiarelli, S. Quinzani et al. Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations. Orphanet. J. Rare. Dis. 8, 58 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  5. M. Colombi, C. Dordoni, M. Venturini, C. Ciaccio, S. Morlino et al. Spectrum of mucocutaneous, ocular and facial features and delineation of novel presentations in 62 classical Ehlers-Danlos syndrome patients. Clin. Genet. 92, 624–631 (2017)

    Article  CAS  PubMed  Google Scholar 

  6. M. Castori, B. Tinkle, H. Levy, R. Grahame, F. Malfait, A. Hakim, A framework for the classification of joint hypermobility and related conditions. A continuous spectrum of phenotypes exists grouping together patients with isolated, non-syndromic joint hypermobility, HSD and hEDS. Am. J. Med. Genet. C. Semin. Med. Genet. 175(1), 148–157 (2017)

    Article  PubMed  Google Scholar 

  7. M. Castori, A. Hakim, Contemporary approach to joint hypermobility and related disorders. Curr. Opin. Pediatr. 29(6), 640–649 (2017)

    Article  PubMed  Google Scholar 

  8. Y. Gazit, G. Jacob, R. Grahame, Ehlers–Danlos syndrome—hypermobility type: a much neglected multisystemic disorder. Rambam Maimonides Med 7, 1–10 (2016)

    Google Scholar 

  9. A.A. Deodhar, A.D. Woolf, Ehlers-Danlos syndrome and osteoporosis. Ann. Rheum. Dis. 53, 841–842 (1994)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. P.C. Coelho, R. Santos, J.A. Gomes, Osteoporosis and Ehlers-Danlos syndrome. Ann. Rheum. Dis. 53, 212–213 (1994)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. A.L. Dolan, N.K. Arden, R. Grahame, T.D. Spector, Assessment of bone in Ehlers Danlos syndrome by ultrasound and densitometry. Ann. Rheum. Dis. 57, 630–633 (1998)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. G. Mazziotti, C. Dordoni, M. Doga, F. Galderisi et al. High prevalence of radiological vertebral fractures in adult patients with Ehlers–Danlos syndrome. Bone 84, 88–92 (2016)

    Article  CAS  PubMed  Google Scholar 

  13. C. Eller-Vainicher, A. Bassotti, A. Imeraj, E. Cairoli et al. Bone involvement in adult patients affected with Ehlers-Danlos syndrome. Osteoporos. Int. 27, 2525–2531 (2016)

    Article  CAS  PubMed  Google Scholar 

  14. S. Bonadonna, G. Mazziotti, M. Nuzzo, A. Bianchi et al. Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J. Bone Miner. Res. 30, 1837–1844 (2005)

    Article  Google Scholar 

  15. G. Mazziotti, M. Doga, S. Frara, F. Maffezzoni et al. Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine 52, 103–110 (2016)

    Article  CAS  PubMed  Google Scholar 

  16. G. Mazziotti, A. Delgado, F. Maffezzoni, A. Formenti et al. Skeletal fragility in endogenous hypercortisolism. Front. Horm. Res. 46, 66–73 (2016)

    Article  CAS  PubMed  Google Scholar 

  17. P. Beighton, A. De Paepe, B. Steinmann, P. Tsipouras et al. Ehlers–Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers–Danlos National Foundation (USA) and Ehlers–Danlos Support Group (UK). Am. J. Med. Genet. 77, 31–37 (1998)

    Article  CAS  PubMed  Google Scholar 

  18. J.T. Schousboe, J.A. Shepherd, J.P. Bilezikian et al. Executive summary of the2013 International Society for Clinical Densitometry position development conference on bone densitometry. J. Clin. Densitom. 16, 455–466 (2013)

    Article  PubMed  Google Scholar 

  19. J.F. Griffith, H.K. Genant, New advances in imaging osteoporosis and its complications. Endocrine 42, 39–51 (2012)

    Article  CAS  PubMed  Google Scholar 

  20. R.T. Franceschi, The developmental control of osteoblast specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit. Rev. Oral. Biol. Med. 10, 40–57 (1999)

    Article  CAS  PubMed  Google Scholar 

  21. C. Ge, Q. Yang, G. Zhao, H. Yu et al. Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. J. Bone Miner. Res. 27, 538–551 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. G.S. Schultz, J.M. Davidson, R.S. Kirsner, P. Bornstein et al. Dynamic reciprocity in the wound microenvironment. Wound Rep. Reg. 19, 134–148 (2011)

    Article  Google Scholar 

  23. T. Palomo, T. Vilaça, M. Lazaretti-Castro, Osteogenesis imperfecta: diagnosis and treatment. Curr. Opin. Endocrinol. Diabetes Obes. 24, 381–388 (2017)

    Article  CAS  PubMed  Google Scholar 

  24. M. Fiscaletti, C.P. Coorey, A. Biggin, J. Briody, Diagnosis of recurrent fractures in a pediatric cohort. Calcif. Tissue Int. 103(5), 529–539 (2018). https://doi.org/10.1007/s00223-018-0449-6

    Article  CAS  PubMed  Google Scholar 

  25. J. Lim, I. Grafe, S. Alexander, B. Lee, Genetic causes and mechanisms of osteogenesis imperfecta. Bone 102, 40–49 (2017)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. N. Chiarelli, G. Carini, N. Zoppi, C. Dordoni, M. Ritelli, M. Venturini, M. Castori, M. Colombi, Transcriptome-wide expression profiling in skin fibroblasts of patients with joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type. PLoS ONE 11(8), e0161347 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. N. Zoppi, N. Chiarelli, S. Binetti, M. Ritelli, M. Colombi, Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders. Biochem Biophys. Acta 1864(4 Pt A), 1010–1023 (2018)

    CAS  Google Scholar 

  28. S. Shuster, Osteoporosis, a unitary hypothesis of collagen loss in skin and bone. Med. Hypotheses 65, 426–432 (2005)

    Article  CAS  PubMed  Google Scholar 

  29. L. Carbone, F.A. Tylavsky, A.J. Bush, W. Koo et al. Bone density in Ehlers–Danlos syndrome. Osteoporos. Int. 11, 388–392 (2000)

    Article  CAS  PubMed  Google Scholar 

  30. M.F. Holick, A. Hossein-Nezhad, F. Tabatabaei, Multiple fractures in infants who have Ehlers–Danlos/hypermobility syndrome and or vitamin D deficiency: a case series of 72 infants whose parents were accused of child abuse and neglect. Dermatoendocrinol 9(1), e1279768 (2017). https://doi.org/10.1080/19381980.2017.1279768

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. M. Yamashita, K. Hasegawa, Y. Higuchi, T. Miyai et al. Urinary cross-linked N-terminal telopeptide of type I collagen levels of infants with Osteogenesis Imperfecta and healthy infants. Acta Med. Okayama 70, 435–439 (2016)

    CAS  PubMed  Google Scholar 

  32. E. Aström, P. Magusson, S. Eksborg, S. Söderhäll, Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with Osteogenesis Imperfecta. Acta Paediatr. 99, 1834–1840 (2010)

    Article  CAS  PubMed  Google Scholar 

  33. G. Mazziotti, A.M. Formenti, S. Frara, R. Olivetti et al. High prevalence of radiological vertebral fractures in women on thyroid-stimulating hormone-suppressive therapy for thyroid carcinoma. J. Clin. Endocrinol. Metab. 103, 956–964 (2017)

    Article  Google Scholar 

  34. D. Diacinti, D. Pisani, M. D”Avanzo, M. Celli et al. Reliability of vertebral fractures assessment (VFA) in children with Osteogenesis Imperfecta. Calcif. Tissue 96, 307–312 (2015)

    Article  CAS  Google Scholar 

  35. C. Grey, R. Young, P.W. Bearcroft, J.E. Compston, Vertebral deformity in the thoracic spine in post-menopausal women: value of lumbar spine bone density. Br. J. Radiol. 69, 137–42 (1996)

    Article  CAS  PubMed  Google Scholar 

  36. G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41, 58–69 (2012)

    Article  CAS  PubMed  Google Scholar 

  37. G. Mazziotti, S. Frara, A. Giustina, Pituitary diseases and bone. Endocr. Rev. 39, 440–488 (2018). https://doi.org/10.1210/err.2018-00005

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Giustina.

Ethics declarations

Conflict of interest

A.G. is consultant for Abiogen. The remaining authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any experimental studies with human participants performed by any of the authors. Data collected from routine evaluation of two patients are reported.

Informed consent

Informed consent was obtained from the two patients whose routine data were reported in the manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Formenti, A.M., Doga, M., Frara, S. et al. Skeletal fragility: an emerging complication of Ehlers–Danlos syndrome. Endocrine 63, 225–230 (2019). https://doi.org/10.1007/s12020-018-1822-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-018-1822-y

Keywords

Navigation